GO:0004672 protein kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004672 (protein kinase activity) is a molecular function ontology term describing the ATP-dependent transfer of a phosphate group to a protein substrate.
• Protein kinases are central to signal transduction, metabolism, cell cycle control, and stress responses, and their dysregulation underlies cancer, metabolic disease, and neurodegeneration.
• AMPK (PRKAA1/PRKAA2) is a well-characterized protein kinase whose activity is regulated by exercise, energy stress, and pharmacological activators.
• p38 MAPK (MAPK14) exemplifies how protein kinase signaling in skeletal muscle controls systemic physiology such as locomotor activity.
• CRISPR knockout, point-mutation knock-in, and overexpression models enable causal dissection of kinase function in human cells and animal models.
• High-throughput CRISPR library screening and bioinformatics can identify kinase dependencies and resistance mechanisms for drug discovery.
Description
Protein kinase activity (GO:0004672) is a fundamental molecular function in which an enzyme transfers the gamma-phosphate of ATP to the hydroxyl group of serine, threonine, or tyrosine residues on protein substrates. This phosphorylation event acts as a reversible molecular switch that alters substrate conformation, localization, interaction partners, or catalytic activity, thereby propagating signals within cells. Because kinases constitute one of the largest gene families in eukaryotes, they are essential for nearly every cellular process, including metabolism, growth, differentiation, and apoptosis. Researchers study protein kinase activity to understand normal physiology and to develop therapeutics for diseases driven by aberrant kinase signaling. The AMP-activated protein kinase (AMPK) is a paradigmatic example: its activity is exquisitely sensitive to cellular energy charge and is modulated by exercise, hormones, and pharmacological agents. Similarly, p38 MAPK signaling in skeletal muscle has been shown to regulate systemic locomotor activity through IL-15. These examples illustrate why GO:0004672 is a high-priority target for functional genomics and drug discovery.
protein kinase activity At A Glance
| GO ID | GO:0004672 |
|---|---|
| GO term | protein kinase activity |
| Ontology | molecular_function |
| Synonym | None listed in QuickGO |
| Major function | ATP-dependent phosphorylation of protein substrates on Ser/Thr/Tyr residues |
| Catalytic activity | Transfer of gamma-phosphate from ATP to protein hydroxyl groups |
| Regulatory role | Central to signal transduction, metabolism, cell cycle, and stress responses |
| Representative kinases | AMPK (PRKAA1/PRKAA2), p38 MAPK (MAPK14), and many others |
| Disease relevance | Cancer, metabolic disorders, neurodegeneration, and inflammatory diseases |
What Is GO:0004672?
Protein kinase activity (GO:0004672) is defined as the catalysis of the transfer of a phosphate group from ATP to a protein acceptor, typically on serine, threonine, or tyrosine residues. This post-translational modification is mediated by a conserved kinase domain that binds ATP and the substrate and facilitates phosphotransfer. The reaction is reversible through the action of protein phosphatases, allowing dynamic regulation of signaling networks. In QuickGO, GO:0004672 is classified under molecular function and is a child of transferase activity, transferring phosphorus-containing groups. The term encompasses all protein kinases regardless of substrate specificity, including serine/threonine kinases such as AMPK and MAPKs, and tyrosine kinases.
Why Is protein kinase activity Important in Cell Biology?
Protein kinase activity is one of the most intensively studied molecular functions because it governs virtually all signal transduction pathways and is frequently dysregulated in human disease. Kinases are the second most common class of drug targets, with numerous small-molecule inhibitors approved for cancer and inflammatory diseases. Understanding kinase function through genetic models is therefore critical for both basic biology and translational medicine.
• Protein kinases regulate glucose uptake and glycogen synthesis in skeletal muscle, with AMPK being a key mediator.
• Exercise activates AMPK in pancreatic islets, linking energy metabolism to cellular senescence.
• p38 MAPK signaling in muscle controls locomotor activity via IL-15, demonstrating systemic effects of kinase activity.
• AMPK is a master regulator of metabolic control and is implicated in type 2 diabetes and obesity.
• Kinase activity is essential for cell cycle progression and its deregulation drives oncogenesis.
• Protein kinases are major drug targets; kinase inhibitors are used to treat cancers and inflammatory diseases.
• Transgenic models have been instrumental in defining the regulatory role of AMPK in exercise-induced metabolism.
• Endurance training modulates AMPK activity and expression in human skeletal muscle, highlighting plasticity.
• Kinase signaling integrates hormonal and nutritional cues to maintain energy homeostasis.
• CRISPR-based screens can systematically identify kinase dependencies in cancer and other diseases.
Molecular Mechanism of protein kinase activity
ATP binding and substrate recognition
In simple terms: The kinase grabs an ATP molecule and holds the target protein in place.
Protein kinases contain a conserved catalytic domain that binds ATP in a cleft between the N- and C-terminal lobes. The gamma-phosphate of ATP is positioned for transfer to the hydroxyl group of a serine, threonine, or tyrosine residue on the substrate. Substrate specificity is determined by the kinase's activation loop, docking motifs, and scaffolding interactions. For AMPK, binding of AMP or ADP to the gamma subunit allosterically promotes activation by upstream kinases.
Phosphotransfer and product release
In simple terms: The phosphate is transferred from ATP to the target protein, and the products are released.
The catalytic step involves a conserved aspartate residue that acts as a general base to deprotonate the substrate hydroxyl, facilitating nucleophilic attack on the ATP gamma-phosphate. Following phosphotransfer, ADP and the phosphorylated protein are released, allowing the kinase to cycle. This reaction is reversible through the action of protein phosphatases, which remove the phosphate group.
Allosteric regulation and activation loop phosphorylation
In simple terms: Many kinases need a second phosphorylation event to become fully active.
Most kinases require phosphorylation of their activation loop by upstream kinases or autophosphorylation to achieve full catalytic activity. For example, AMPK is activated by LKB1 (STK11) or CaMKK2 (CAMKK2)-mediated phosphorylation of Thr172 in the alpha subunit. This creates a switch that integrates energy status with downstream metabolic responses.
Subcellular localization and scaffolding
In simple terms: Kinases are directed to specific parts of the cell where they meet their targets.
Protein kinases are often anchored to specific subcellular compartments through scaffolding proteins, lipid modifications, or targeting sequences. This spatial regulation ensures that phosphorylation events occur at the right place and time. For instance, AMPK is found in the cytoplasm and nucleus, and its localization can influence substrate selection.
Signal integration and crosstalk
In simple terms: Kinases talk to each other to coordinate complex cellular responses.
Protein kinase activity is embedded in signaling networks with extensive crosstalk. For example, AMPK and p38 MAPK can be co-activated by exercise or stress, and they modulate overlapping metabolic and transcriptional programs. Such integration allows cells to fine-tune responses to diverse stimuli.
Key Genes Involved in GO:0004672 protein kinase activity
The following genes encode protein kinases or closely related regulators that are central to the function of GO:0004672, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRKAA1 | Catalytic alpha-1 subunit of AMPK; phosphorylates metabolic substrates | Target for metabolic disease and exercise mimetics |
| PRKAA2 | Catalytic alpha-2 subunit of AMPK; regulates glucose uptake and glycogen synthesis | Key mediator of exercise-induced metabolic adaptations |
| PRKAB1 | Non-catalytic beta-1 subunit of AMPK; scaffolds substrate binding | Modulates AMPK activity and stability |
| PRKAG1 | Gamma-1 subunit of AMPK; binds AMP/ADP for allosteric regulation | Determines energy-sensing properties of AMPK |
| STK11 | Upstream kinase LKB1; phosphorylates and activates AMPK | Tumor suppressor frequently mutated in Peutz-Jeghers syndrome |
| CAMKK2 | Upstream kinase CaMKK2; activates AMPK in response to calcium | Links calcium signaling to energy metabolism |
| MAPK14 | p38 MAPK alpha; stress-activated kinase regulating muscle physiology | Controls locomotor activity via IL-15 in muscle |
| MAPK11 | p38 MAPK beta; stress-activated kinase with overlapping functions | Potential redundancy with MAPK14 in muscle |
| MAP2K3 | MKK3; upstream kinase that phosphorylates p38 MAPK | Part of the p38 MAPK cascade in skeletal muscle |
| MAP2K6 | MKK6; upstream kinase that phosphorylates p38 MAPK | Part of the p38 MAPK cascade in skeletal muscle |
| AKT1 | Serine/threonine kinase in PI3K signaling; regulates growth and survival | Oncogene and drug target in cancer |
| MTOR | Serine/threonine kinase; master regulator of cell growth and metabolism | Target of rapamycin and rapalogs in cancer and transplantation |
| EGFR | Receptor tyrosine kinase; activates MAPK and PI3K pathways | Major drug target in lung and breast cancer |
| SRC | Non-receptor tyrosine kinase; regulates proliferation and adhesion | Oncogene and target in leukemia and solid tumors |
| CDK1 | Cyclin-dependent kinase 1; controls cell cycle progression | Target for cancer therapy and cell cycle research |
| CDK2 | Cyclin-dependent kinase 2; regulates S phase and DNA replication | Target for cancer and regenerative medicine |
| MAPK1 | ERK2; terminal kinase of the MAPK/ERK pathway | Driver of proliferation in many cancers |
| MAPK3 | ERK1; terminal kinase of the MAPK/ERK pathway | Driver of proliferation in many cancers |
How Is protein kinase activity Regulated?
Protein kinase activity is regulated at multiple levels, including allosteric activation by second messengers (e.g., AMP, ADP, calcium), phosphorylation by upstream kinases, interaction with regulatory subunits, and subcellular localization. For AMPK, energy stress increases the AMP/ATP ratio, promoting AMP binding to the gamma subunit and allosteric activation, as well as protecting against dephosphorylation of Thr172. Exercise and endurance training modulate AMPK activity and expression in human skeletal muscle, demonstrating physiological regulation. In pancreatic islets, exercise activates AMPK to decrease senescence, linking systemic physiology to kinase regulation. Additionally, p38 MAPK signaling in muscle is regulated by upstream MAP2Ks and controls locomotor activity via IL-15. These examples illustrate the diverse mechanisms that fine-tune protein kinase activity in health and disease.
protein kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRKAA1 | Type 2 diabetes, metabolic syndrome | Knockout and point-mutation knock-in in human skeletal muscle cells |
| MAPK14 | Muscle wasting, inflammation, locomotor dysfunction | Muscle-specific knockout and overexpression in mouse models |
| EGFR | Non-small cell lung cancer, glioblastoma | CRISPR knockout and point-mutation knock-in in cancer cell lines |
| STK11 | Peutz-Jeghers syndrome, lung cancer | Knockout and knock-in of patient mutations in organoids |
| MTOR | Cancer, transplant rejection, metabolic disease | Overexpression and point-mutation knock-in in cell lines |
Cancer
Dysregulated protein kinase activity is a hallmark of cancer, with activating mutations or overexpression of kinases such as EGFR, SRC, and AKT driving proliferation and survival. Kinase inhibitors targeting these pathways have revolutionized treatment for subsets of lung, breast, and hematological malignancies. CRISPR screens can identify kinase dependencies and resistance mechanisms, guiding combination therapies.
Metabolic disorders
AMPK activity is central to glucose homeostasis and lipid metabolism, and its dysregulation is implicated in type 2 diabetes and obesity. Transgenic models have shown that AMPK regulates glucose transport and glycogen synthase activity in skeletal muscle, making it a therapeutic target for insulin resistance. Exercise activates AMPK in pancreatic islets, suggesting a role in islet function and senescence.
Neurodegeneration and aging
Altered kinase signaling contributes to neurodegenerative diseases and aging-related pathologies. AMPK activation has been linked to neuroprotective effects in models of metabolic stress, although context-dependent outcomes are observed. The p38 MAPK pathway is also implicated in stress responses and muscle wasting, affecting locomotor activity.
Inflammatory and immune disorders
Protein kinases such as p38 MAPK and SRC are key mediators of inflammatory cytokine production and immune cell activation. Inhibitors of these kinases are in clinical development for rheumatoid arthritis and other inflammatory conditions. Understanding kinase regulation in immune cells is essential for optimizing therapeutic strategies.
From protein kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of AMPK catalytic activity impair glucose uptake? | PRKAA1/PRKAA2 double knockout in human myotubes |
| Does a specific point mutation in MAPK14 alter locomotor activity? | MAPK14 point-mutation knock-in in mouse muscle |
| Can overexpression of a constitutively active kinase drive senescence? | Inducible overexpression of PRKAA1 in pancreatic islets |
| What is the subcellular localization of a tagged kinase? | Endogenous knock-in of GFP or HA tag at the kinase locus |
| Which kinases are essential for cancer cell proliferation? | Genome-wide CRISPR knockout library screening |
| Does a disease-associated kinase variant alter drug sensitivity? | Point-mutation knock-in of the variant in isogenic cell lines |
How to Study the protein kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro kinase assay | Catalytic activity of a purified kinase | Enzyme kinetics and inhibitor screening |
| Phosphoproteomics | Global phosphorylation changes | Substrate identification and pathway mapping |
| CRISPR knockout screen | Gene essentiality and drug resistance | Kinome-wide functional genomics |
| FRET biosensor imaging | Real-time kinase activity in live cells | Spatiotemporal signaling dynamics |
| Western blot with phospho-specific antibodies | Phosphorylation status of specific substrates | Validation of kinase activation |
| RNA-seq | Transcriptional changes downstream of kinase signaling | Pathway analysis and biomarker discovery |
| Proximity labeling (BioID) | Protein-protein interactions of kinases | Identification of kinase complexes |
| Bioinformatics pathway analysis | Enrichment of signaling networks | Interpretation of omics data |
Kinase activity assays
In vitro kinase assays using recombinant enzymes and peptide substrates measure catalytic activity and are used to screen inhibitors. For AMPK, activity is often assessed by phosphorylation of specific substrates such as ACC1/2 or by using commercial kits. These assays provide direct biochemical evidence of protein kinase activity.
Phosphoproteomics
Mass spectrometry-based phosphoproteomics identifies global changes in protein phosphorylation upon kinase activation or inhibition. This approach can reveal novel substrates and signaling networks downstream of a kinase of interest. It is particularly powerful when combined with genetic models such as knockout or knock-in.
CRISPR screening
Pooled CRISPR knockout or activation screens enable systematic discovery of kinases required for a phenotype, such as drug resistance or proliferation. Libraries targeting the kinome can identify synthetic lethal interactions and guide drug development. Bioinformatics analysis of screen data prioritizes candidate kinases for follow-up.
Live-cell imaging and biosensors
Genetically encoded FRET biosensors can monitor kinase activity in real time in living cells. These tools allow spatial and temporal resolution of signaling dynamics. For example, AMPK biosensors have been used to track energy stress responses.
How CRISPR Can Be Used to Study GO:0004672 protein kinase activity
Knockout
CRISPR knockout of a kinase gene eliminates its protein product, enabling loss-of-function studies. For example, knockout of PRKAA1 and PRKAA2 in human muscle cells can reveal their role in glucose uptake. Knockout models are essential for validating drug targets and understanding kinase dependencies.
Point Mutation
CRISPR point-mutation knock-in introduces specific amino acid substitutions, such as kinase-dead or constitutively active variants. This allows precise dissection of catalytic activity versus scaffolding functions. For instance, mutation of the AMPK Thr172 phosphorylation site can prevent activation by upstream kinases.
Knock-in
Knock-in of reporter tags (e.g., GFP, HA) or disease-associated alleles enables tracking of endogenous kinase expression and localization. Knock-in of patient mutations in isogenic cell lines can model disease and test drug responses. This approach is valuable for studying kinase variants of uncertain significance.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase kinase levels to study gain-of-function effects. Overexpression of constitutively active kinases can drive transformation or senescence in appropriate models. This complements knockout studies by providing bidirectional modulation of kinase activity.
How EDITGENE Supports protein kinase activity Research
Researchers studying protein kinase activity-related genes often need to determine whether a candidate gene is causally involved in a phenotype, and CRISPR-based models provide the most direct way to establish causality. Whether the goal is to eliminate kinase function, introduce a specific disease variant, tag the endogenous protein, or overexpress a constitutively active form, EDITGENE offers tailored solutions to accelerate discovery.
Contact EDITGENE today to design your custom CRISPR model for protein kinase activity research.
Frequently Asked Questions About protein kinase activity
What is protein kinase activity GO:0004672?
Protein kinase activity (GO:0004672) is a molecular function describing the ATP-dependent transfer of a phosphate group to a protein substrate, typically on serine, threonine, or tyrosine residues.
What genes are involved in protein kinase activity?
Genes encoding kinases such as PRKAA1, PRKAA2, MAPK14, EGFR, SRC, AKT1, MTOR, and CDK1 are central to protein kinase activity.
How is protein kinase activity regulated?
It is regulated by allosteric activators (e.g., AMP, calcium), phosphorylation by upstream kinases, regulatory subunits, and subcellular localization.
What diseases are associated with protein kinase activity?
Dysregulated kinase activity is linked to cancer, type 2 diabetes, obesity, neurodegeneration, and inflammatory disorders.
How can I study protein kinase activity in the lab?
Common methods include in vitro kinase assays, phosphoproteomics, Western blotting with phospho-specific antibodies, and CRISPR screens.
What is the role of AMPK in protein kinase activity?
AMPK is a serine/threonine kinase activated by energy stress; it regulates glucose uptake, glycogen synthesis, and metabolic homeostasis.
Can CRISPR be used to study protein kinase activity?
Yes, CRISPR knockout, point-mutation knock-in, and overexpression models enable causal studies of kinase function and drug response.
What is the difference between protein kinase and phosphatase activity?
Protein kinases add phosphate groups to proteins, while phosphatases remove them; together they control reversible phosphorylation.
Which kinase is activated by exercise?
AMPK is activated by exercise in skeletal muscle and pancreatic islets, leading to metabolic adaptations.
How does p38 MAPK affect muscle function?
p38 MAPK signaling in muscle regulates locomotor activity via IL-15 and is involved in stress responses.
Conclusion
Protein kinase activity (GO:0004672) is a cornerstone of cellular signaling, with profound implications for metabolism, growth, and disease. The AMPK and p38 MAPK pathways exemplify how kinase activity integrates physiological cues such as exercise and stress to control systemic functions. Advances in CRISPR-based models and high-throughput screening are accelerating the functional annotation of kinases and the development of targeted therapeutics. Continued research on GO:0004672 will undoubtedly yield new insights into human health and disease.
References
- 1. Spaulding HR et al.. 2022. AMPK and the Adaptation to Exercise.. Annu Rev Physiol 84:209-227 PMID: 35143330
- 2. Wojtaszewski JF et al.. 2003. Transgenic models--a scientific tool to understand exercise-induced metabolism: the regulatory role of AMPK (5'-AMP-activated protein kinase) in glucose transport and glycogen synthase activity in skeletal muscle.. Biochem Soc Trans 31(Pt 6):1290-4 PMID: 14641045
- 3. Carapeto P et al.. 2024. Exercise activates AMPK in mouse and human pancreatic islets to decrease senescence.. Nat Metab 6(10):1976-1990 PMID: 39317751
- 4. Folgueira C et al.. 2024. Remodeling p38 signaling in muscle controls locomotor activity via IL-15.. Sci Adv 10(33):eadn5993 PMID: 39141732
- 6. Viollet B et al.. 2011. AMP-activated protein kinase and metabolic control.. Handb Exp Pharmacol PMID: 21484577
- 7. Frøsig C et al.. 2004. 5'-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle.. Am J Physiol Endocrinol Metab 286(3):E411-7 PMID: 14613924
- 8. Jeon SM. 2016. Regulation and function of AMPK in physiology and diseases.. Exp Mol Med 48(7):e245 PMID: 27416781
